To clearly understand the effect of T2DM and drugs for T2DM and COVID-19, we chose metformin, insulin, sulfonylureas, glinides, α-glucosidase inhibitors (AGIs), and DPP4 inhibitors as our targets. The gene discussed is DPP4; the disease is type 2 diabetes mellitus.